Ads
related to: darzalex approval- Learn About IMDELLTRA™
View Efficacy and Safety Data
Prescribing Information for HCPs
- Contact Amgen Support+
Discover Patient & HCP Support
Request a Representative
- IMDELLTRA™ Clinical Data
See Data From Clinical Trials
View Dosing Information
- IMDELLTRA™ Safety Info
View Safety Data
Find Safety Profile Information
- IMDELLTRA™ Dosing Info
Review Dosing & Admin Information
For Newly FDA Approved Treatment
- Download HCP Resources
View & Download Physician Resources
Get Dosing Guide & Patient Brochure
- Learn About IMDELLTRA™
Search results
Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme
Investor's Business Daily· 1 year agoConfusion over new Medicare negotiating plans sent Regeneron Pharmaceuticals and Halozyme...
Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters via Yahoo Finance· 10 months agoInjectable versions of some widely-used cancer drugs including Johnson & Johnson's blockbuster...
Halozyme (HALO) Q1 Earnings Disappoint, Revenues Rise Y/Y
Zacks via Yahoo Finance· 1 year agoHalozyme Therapeutics, Inc. HALO reported first-quarter 2023 adjusted earnings of 47 cents per...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript May 7, 2024 Halozyme...
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoGenmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings...
Halozyme's (HALO) ENHANZE Drives Stock: Rally to Continue?
Zacks via Yahoo Finance· 2 years agoHalozyme's (HALO) revenues are driven by strong demand for new partnered drugs developed using...
Halozyme (HALO) Q2 Earnings & Revenues Beat, 2023 View Raised
Zacks via Yahoo Finance· 10 months agoHalozyme (HALO) shares rise 4% in the after-market trading hours on better-than-expected...
HALO Stock: Halozyme Gets Under Your Skin To Deliver Blockbuster Drugs And Booming Growth
Investor's Business Daily· 2 years agoHalozyme's under-the-skin technology helps deliver some of the biggest moneymaking injections,...
Halozyme Therapeutics (HALO) Down 3.8% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 9 months agoIt has been about a month since the last earnings report for Halozyme Therapeutics (HALO). Shares...
GSK cancer drug Blenrep gets surprise trial win
BioPharma Dive via Yahoo Finance· 6 months agoOne year after the U.K. drugmaker withdrew the multiple myeloma drug from the U.S. market because of negative data, new study results might crack open...
Ads
related to: darzalex approval